You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nasopharyngeal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, Nasopharyngeal Cancer, Chemo-induced Nausea and Vomiting Trial in Shantou (Fosaprepitant, tropisetron,

Recruiting
  • Cervical Cancer
  • +4 more
  • Shantou, Guangdong, China
    Cancer Hospital of Shantou University Medical College
Sep 29, 2022

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Nivolumab
  • +5 more
  • (no location specified)
Aug 21, 2023

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • FDG-PET
  • Galium-68 DOTATATE
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

Recruiting
  • Nasopharyngeal Cancer
  • Toripalimab
  • Induction chemotherapy and concurrent chemoradiation
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Nov 25, 2022

Nasopharyngeal Cancer Trial in Jakarta (Auto-Dendritic Adjuvant Therapy, Allo-Dendritic-Secretome Adjuvant Therapy)

Not yet recruiting
  • Nasopharyngeal Cancer
  • Auto-Dendritic Adjuvant Therapy
  • Allo-Dendritic-Secretome Adjuvant Therapy
  • Jakarta, Indonesia
    PT Prodia StemCell Indonesia
Mar 1, 2022

Nasopharyngeal Carcinoma Trial in Brescia (Pembrolizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Mar 29, 2022

Intrinsic Radiation Sensitivity in Cancer Patients

Recruiting
  • Nasopharyngeal Cancer
  • +2 more
    • Singapore, Singapore
      National Cancer Center Singapore
    Dec 1, 2022

    Nasopharyngeal Cancer Trial in Singapore (cisplatin and gemcitabine, induction chemo cisplatin, gemcitabine, bevacizumab and

    Not yet recruiting
    • Nasopharyngeal Cancer
    • cisplatin and gemcitabine
    • induction chemotherapy cisplatin, gemcitabine, bevacizumab and pembrolizumab.
    • Singapore, Singapore
      National University Hospital
    Mar 22, 2022

    Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

    Recruiting
    • Nasopharyngeal Cancer
    • Epstein-Barr Virus Related Carcinoma
    • Stanford, California
      Stanford University
    Mar 31, 2022

    Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

    Not yet recruiting
    • Metastatic Nasopharyngeal Carcinoma
    • +2 more
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Jun 13, 2023

    Metastatic Nasopharyngeal Cancer Trial in Shenzhen (Radiotherapy)

    Recruiting
    • Metastatic Nasopharyngeal Cancer
    • Radiotherapy
    • Shenzhen, China
      National Cancer Center/National Clinical Research Center for Can
    May 21, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in Shanghai (Fluzoparib and Camrelizumab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Fluzoparib and Camrelizumab
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Jun 4, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Bengbu, Anhui, China
    • +12 more
    Dec 13, 2022

    Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Endostar and Envafolimab
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 24, 2023

    Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity

    Not yet recruiting
    • Nasopharyngeal Carcinoma
      • Fuzhou, Fujian, China
        Department of radiation oncology, Fujian cancer hospital
      Nov 16, 2023

      Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

      Recruiting
      • Nasopharyngeal Carcinoma
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Apr 2, 2023

      Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma

      Not yet recruiting
      • Stage IVA Nasopharyngeal Carcinoma
      • Intensity modulated radiation therapy (IMRT) combined with chemotherapy
      • Nanjing, China
        Jiangsu Cancer Hospital
      Jun 21, 2023

      Nasopharyngeal Carcinoma, Radiotherapy; Complications Trial (Intensity Modulated Radiation Therapy, Chemotherapy)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • Radiotherapy; Complications
      • (no location specified)
      Mar 20, 2023

      Head Neck Cancer Trial in Singapore (carboplatin,, cisplatin, gemcitabine HCl)

      Active, not recruiting
      • Head and Neck Cancer
      • Singapore, Singapore
        National Cancer Centre - Singapore
      Sep 27, 2022

      Nasopharyngeal Carcinoma, Iron-deficiency, Anemia Trial in Guangzhou (Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill,

      Recruiting
      • Nasopharyngeal Carcinoma
      • +2 more
      • Iron Isomaltoside 1000
      • +2 more
      • Guangzhou, Guangdong, China
        Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
      Jun 19, 2023

      Nasopharyngeal Carcinoma, Recurrent Cancer Trial in Guangzhou (Tranilast)

      Recruiting
      • Nasopharyngeal Carcinoma
      • Recurrent Cancer
      • Guangzhou, Guangdong, China
        Southern medical university
      Nov 15, 2022

      Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)

      Recruiting
      • Nasopharyngeal Carcinoma
      • Guangzhou, Guangdong, China
        Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
      May 3, 2023

      Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

      Recruiting
      • Nasopharyngeal Carcinoma
      • +3 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Nov 3, 2022

      Nasopharyngeal Carcinoma Trial in Beijing (Donafenib)

      Recruiting
      • Nasopharyngeal Carcinoma
      • Beijing, Beijing, China
        Cancer Hospital of Medical College
      Nov 28, 2022

      Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy Trial in Zhongshan (Reduction CTVp1, Non-reduction CTVp1)

      Recruiting
      • Nasopharyngeal Carcinoma
      • Intensity-Modulated Radiotherapy
      • Reduction CTVp1
      • Non-reduction CTVp1
      • Zhongshan, Guangdong, China
        Zhongshan City People's Hospital
      Aug 8, 2023